Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.05230-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Jiayou Luo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Gastrointestinal Microbiome, Pediatric Obesity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Children's Hospital of Xiangya Medical College Project.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Altered gut microbiota and metabolites are important for non-alcoholic fatty liver disease (NAFLD) in children. We aimed to comprehensively examine the effects of gut metabolites on NAFLD progression. We performed integrative metabolomics (untargeted discovery and targeted validation) analysis of non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH), and obesity in children. Fecal samples were collected from 75 subjects in the discovery cohort (25 NAFL, 25 NASH, and 25 obese control children) and 145 subjects in an independent validation cohort (53 NAFL, 39 NASH, and 53 obese control children). Among 2,491 metabolites, untargeted metabolomics revealed a complete NAFLD metabolic map containing 318 increased and 123 decreased metabolites. Then, machine learning selected 65 important metabolites that can distinguish the severity of the NAFLD. Furthermore, precision-targeted metabolomics selected 5 novel gut metabolites from 20 typical metabolites. The functionality of candidate metabolites was validated in hepatocyte cell lines. In the end, this study annotated two novel elevated pathogenic metabolites (dodecanoic acid and creatinine) and a relationship between depleted protective gut microbiota ( Butyricicoccus and Alistipes ), increased inflammation (IL-1β), lipid metabolism (TG), and liver function (ALT and AST). This study demonstrates the role of novel gut metabolites (dodecanoic acid and creatinine), as the fatty acid metabolism regulator contributing to NAFLD development through its influence on inflammation and liver function. IMPORTANCE Altered gut microbiota and metabolites are a major cause of non-alcoholic fatty liver disease (NAFLD) in children. This study demonstrated a complete gut metabolic map of children with NAFLD, containing 318 increased and 123 decreased metabolites by untargeted metabolomic. Multiple validation approaches (machine learning and targeted metabolomic) selected five novel gut metabolites for targeted metabolomics, which can distinguish NAFLD status and severity. The gut microbiota ( Butyricicoccus and Alistipes ) and metabolites (creatinine and dodecanoic acid) were novel biomarkers associated with impaired liver function and inflammation and validated by experiments of hepatocyte cell lines. The data provide a better understanding of the importance of gut microbiota and metabolite alterations in NAFLD, which implies that the altered gut microbiota and metabolites may represent a potential target to prevent NAFLD development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatrics Research Institute of Hunan Province, Hunan Children's Hospital, Changsha, China.
- Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, Changsha, China.
- Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
- Department of Mathematics and Statistics, Mzuzu University, Mzuzu, Malawi.
- Department of Epidemiology and Health Statistics, Medical College of Soochow University, Suzhou, China.
ORCID-Profile: Jiayou Luo, Jia Wei, Xiongfeng Pan
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Children's Hospital of Xiangya Medical College Project
Zitieren
APA
Luo, J., Luo, M., Kaminga, A. C., Wei, J., Dai, W., Peng, Y., Zhao, K., Duan, Y., Xiao, X., Ouyang, S., Yao, Z., Liu, Y., & Pan, X. (2024). Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children. Microbiology Spectrum. https://doi.org/10.1128/spectrum.05230-22
Vancouver
Luo J, Luo M, Kaminga AC, Wei J, Dai W, Peng Y, et al. Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children. Microbiology Spectrum. 2024. doi:10.1128/spectrum.05230-22
BibTeX
@article{Luo2024,
author = {Luo, Jiayou and Luo, Miyang and Kaminga, Atipatsa C and Wei, Jia and Dai, Wen and Peng, Yunlong and Zhao, Kunyan and Duan, Yamei and Xiao, Xiang and Ouyang, SiSi and Yao, Zhenzhen and Liu, Yixu and Pan, Xiongfeng},
title = {Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.05230-22}
}
EUVIMED